An Italian team of scientists, led by EdiVite, has created a genetically edited Chardonnay grape using CRISPR technology that can resist grapevine downy mildew, a disease commonly controlled by pesticides. The DMR6 gene was edited to enhance the production of salicylic acid, a crucial molecule in the plant's immune defense. These vines may not fall under European GMO restrictions, offering a significant advancement towards sustainable and quality wine production. The trial is underway at the University of Verona, with initial data expected in 2025 and wine production expected to begin in 2026. This innovation could potentially reduce the use of fungicides in wine production, which currently accounts for 41% of the total used in European agriculture.